v3.21.2
Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash $ 307,213 $ 1,640,645
Accounts receivable 9,200
Patient financing receivable, current portion 35,080
Other receivables 551 22,123
Prepaid expenses 106,228 94,434
Total Current Assets 458,272 1,757,202
Right-of-use asset 162,207 278,552
Property and equipment, net 40,344 139,175
Patient financing receivable, net of current portion 61,547
Other assets 18,412 29,239
Total assets 740,782 2,204,168
Current Liabilities    
Accounts payable 1,044,727 1,006,968
Accrued liabilities 187,119 276,415
Other current liabilities 141,330 154,812
Notes payable, current portion 67,444 67,444
Convertible notes payable, related parties 1,584,665
Convertible notes payable 1,091,080
PPP Loan, current portion 105,878 606,811
Deferred revenue 410,031 634,149
Lease liability, current portion 92,589 139,189
Interest payable 4,385 6,898
Total Current Liabilities 4,729,248 2,892,686
Long-term Liabilities    
Lease liability, net of current portion 87,304 157,050
PPP Loan, net of current portion 202,271
Total Long-term Liabilities 87,304 359,321
Total Liabilities 4,816,552 3,252,007
Stockholders’ Equity (Deficit)    
Preferred Stock - $.001 par value: 1,000,000,000 shares authorized; Series A Preferred Stock - $.001 par value: 800,000,000 shares authorized, 515,874,354 and 538,109,409 shares issued and outstanding at September 30, 2021 and, December 31, 2020, respectively 515,874 538,109
Common stock - $.001 par value: 1,600,000,000 shares authorized, 149,394,519 and 127,159,464 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively 149,394 127,159
Additional paid-in capital 43,540,358 42,515,999
Accumulated deficit (47,911,264) (43,858,974)
Non-controlling interest (370,132) (370,132)
Total Stockholders’ Deficit (4,075,770) (1,047,839)
Total Liabilities and Stockholders’ Deficit $ 740,782 $ 2,204,168

Source